---
title: "Breakout watch: Savvy investors bet millions on royalty-fueled pharma stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295793482.md"
description: "On the IBD 50 and the latest list of new buys by top funds, Ligand stock targets a breakout but faces this test first."
datetime: "2026-08-13T11:52:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295793482.md)
  - [en](https://longbridge.com/en/news/295793482.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295793482.md)
generator: "portal-rs"
---

# Breakout watch: Savvy investors bet millions on royalty-fueled pharma stock

On the IBD 50 and the latest list of new buys by top funds, Ligand stock targets a breakout but faces this test first.

### Related Stocks

- [LGND.US](https://longbridge.com/en/quote/LGND.US.md)

## Related News & Research

- [$100 Invested In Ligand Pharmaceuticals 10 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/296632631.md)
- [Ranger Investment Management L.P. Acquires Shares of 257,596 Ligand Pharmaceuticals Incorporated $LGND](https://longbridge.com/en/news/296772770.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves](https://longbridge.com/en/news/296514765.md)
- [Analysts Favor Dividend Aristocrats JNJ and LIN Ahead of Q3 Earnings](https://longbridge.com/en/news/296406382.md)
- [Ligand Pharmaceuticals (NASDAQ:LGND) Issues FY 2026 Earnings Guidance](https://longbridge.com/en/news/295123117.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**